PIQTIRIS
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Oct 2025)
What this means for you
This application is over — abandoned 16 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97273776
- Mark type
- Stylized text
- Filed
- 18 Feb 2022
- Published for opposition
- 04 Apr 2023
- Abandoned
- 16 Oct 2025
- Attorney of record
- Connie Ellerbach
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic agents, preparations, and substances for medical purposes; Imaging and therapeutic agents for detecting, diagnosing, and treating cancer, oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders; Preparations and substances for medical purposes for detecting, diagnosing, and treating cancer, oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders; medical diagnostic reagents; reagents for medical use; imaging and detection agents for diagnosing and monitoring cancer, and oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders
- Class 042 — Scientific and technological services: Medical research; scientific research; product research and development; product development in the field of the detection, location, and treatment of diseases; design and development of therapies, diagnostic agents, imaging agents, and medical devices for detecting, locating, and treating cancer and other diseases
Owner
- Blaze Bioscience, Inc., Seattle, WA, US
- Blaze Bioscience, Inc., Seattle, WA, US
Prosecution history
- 16 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 01 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2024 — SOU EXTENSION 3 GRANTED
- 01 Oct 2024 — SOU EXTENSION 3 FILED
- 01 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 03 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2024 — SOU EXTENSION 2 GRANTED
- 02 Apr 2024 — SOU EXTENSION 2 FILED
- 02 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 08 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Nov 2023 — SOU EXTENSION 1 GRANTED
- 06 Nov 2023 — SOU EXTENSION 1 FILED
- 06 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 30 May 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT